Skip to main content
ABBOTT LABORATORIES logo

ABBOTT LABORATORIES — Investor Relations & Filings

Ticker · ABT ISIN · US0028241000 LEI · HQD377W2YR662HK5JX27 US Manufacturing
Open in API
Filings indexed 4,256 across all filing types
Latest filing 2017-02-02 Director's Dealing
Country US United States of America
Listing US ABT

About ABBOTT LABORATORIES

https://www.abbott.com

Abbott Laboratories is a global healthcare company that discovers, develops, manufactures, and sells a broad portfolio of life-changing technologies. The company's operations are focused on four core businesses: Medical Devices, Diagnostics, Nutrition, and Established Pharmaceuticals. The Medical Devices division offers solutions for cardiovascular health, diabetes care (including the FreeStyle Libre continuous glucose monitoring system), and neuromodulation. The Diagnostics segment provides a wide range of in vitro diagnostic systems and tests for hospitals, laboratories, and clinics. The Nutrition business develops and markets science-based nutritional products for people of all ages, with leading brands such as Similac, PediaSure, Ensure, and Glucerna. The Established Pharmaceuticals division provides a portfolio of branded generic medicines to consumers in emerging markets.

Recent filings

Filing Released Lang Actions
FORM 4 -
Director's Dealing
2017-02-02 English
FORM 3 -
Director's Dealing
2017-01-25 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated January 25, 2017. It reports the completion of an acquisition (St. Jude Medical, Inc.) and provides details on the company's new business segments and sales reporting categories starting from Q1 2017. The document includes an exhibit with comparable sales data for 2016. The content is an update on results of operations and financial condition, typical of an 8-K current report. It is not a full annual or quarterly report, nor a detailed earnings release, but a current report on a material event affecting financial condition and operations. Therefore, the filing type is Regulatory Filings (RNS), as 8-Ks are general regulatory announcements and do not fit other more specific categories.
2017-01-25 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated January 25, 2017, by Abbott Laboratories. It specifically references "Item 2.02 Results of Operations and Financial Condition" and includes a press release announcing the company's financial results for the fourth quarter and full year 2016. The document mentions non-GAAP financial measures and management's discussion of these results. The content is consistent with an earnings release, which is typically filed on Form 8-K under Item 2.02 to announce quarterly or annual financial results. The document length is 4476 characters, which is relatively short and focused on announcing results rather than providing comprehensive financial statements or detailed analysis. Therefore, this document is best classified as an Earnings Release (ER).
2017-01-25 English
8-K
Regulatory Filings Classification · 90% confidence The document is a Form 8-K Current Report filed with the SEC, dated January 24, 2017. It reports the completion of an acquisition and provides details on the company's new business segments and comparable sales by product. The key section is Item 2.02, which is "Results of Operations and Financial Condition," indicating it contains financial results information. However, the document is relatively short (4085 characters) and primarily announces operational results and segment reporting changes rather than providing a full quarterly or annual financial report. It does not contain comprehensive financial statements or detailed financial analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). Instead, it is a current report announcing financial results and business updates. Therefore, the best classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit the more specific categories like IR or 10-K.
2017-01-24 English
Major Shareholding Notification 2017
Major Shareholding Notification
2017-01-19 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.